Emerging P2Y12 Receptor Antagonists: Role in Coronary Artery Disease

E-ISSN： 1875-6212|8|1|93-101

ISSN： 1570-1611

Source： Current Vascular Pharmacology, Vol.8, Iss.1, 2010-01, pp. : 93-101

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

P2Y12 Receptor Antagonists in Acute Coronary Syndrome: Clinical Implications of Pharmacologic and Pharmacogenetic Differences

Recent Patents on Cardiovascular Drug Discovery, Vol. 6, Iss. 3, 2011-09 ,pp. : 207-214

Bentham Science Publishers

Access to resources Recommend Favorite

Clopidogrel resistance in North Indian patients of coronary artery disease and lack of its association with platelet ADP receptors P2Y1 and P2Y12 gene polymorphisms

By Kar Rakhee

Platelets, Vol. 24, Iss. 4, 2013-06 ,pp. : 297-302

Informa Healthcare

Access to resources Recommend Favorite

Inhibitory effects of P2Y12 receptor antagonists on TRAP-induced platelet aggregation, procoagulant activity, microparticle formation and intracellular calcium responses in patients with acute coronary syndromes

By Behan Miles W. H. Fox Susan C. Heptinstall Stan Storey Robert F.

Platelets, Vol. 16, Iss. 2, 2005-03 ,pp. : 73-80

Informa Healthcare

Access to resources Recommend Favorite

The P2Y₁₂ receptor as a therapeutic target in cardiovascular disease

By Storey R. F.

Platelets, Vol. 12, Iss. 4, 2001-06 ,pp. : 197-209

Informa Healthcare

Access to resources Recommend Favorite

Effects of P2Y₁ and P2Y₁₂ receptor antagonists on ADP-induced shape change of equine platelets: comparison with human platelets

By Mateos-Trigos G. Evans R.J. Heath M.F.

Platelets, Vol. 13, Iss. 5-6, 2002-08 ,pp. : 285-292

Informa Healthcare

Access to resources Recommend Favorite